Molecular Pathology, Diagnostics, and Therapeutics

Special Issues

Following special issues within this section are currently open for submissions:

• Chlamydia trachomatis Pathogenicity and Disease 2.0 (Deadline: 25 April 2024)
• Cardiovascular Diseases—a Focus on Atherosclerosis, Its Prophylaxis, Complications and Recent Advancements in Therapies 2.0 (Deadline: 25 April 2024)
• Molecular Pathogenesis of Oral Potentially Malignant Disorders Transformation (Deadline: 25 April 2024)
• The Role of Estrogen Receptors in Health and Diseases (Deadline: 28 April 2024)
• Oxidative Stress and Antioxidants in Human Diseases (Deadline: 28 April 2024)
• Obesity and Insulin Resistance: The Dark Sides of Adipose Organ Dysfunction in the Cardiometabolic Continuum (Deadline: 28 April 2024)
• Exploring Molecular Mechanisms of Liver Fibrosis (Deadline: 28 April 2024)
• Molecular Perspective of Cardiovascular Diseases (Deadline: 28 April 2024)
• Cardiac Arrhythmia: Molecular Mechanisms and Therapeutic Strategies (Deadline: 29 April 2024)
• The Human Fetal Membranes: A Versatile Tissue Important for Pregnancy Health and Regenerative Therapies (Deadline: 29 April 2024)
• Autophagy and Immunoregulation in Human Diseases (Deadline: 29 April 2024)
• Molecular Immunity and Defense: Oral and Periodontal Health (Deadline: 30 April 2024)
• Protein Kinase in Disease (Deadline: 30 April 2024)
• Molecular Pathophysiology of Uterine and Ovarian Diseases and Dysfunction 4.0 (Deadline: 30 April 2024)
• Endometriosis: From Molecular Basis to Therapy (Deadline: 30 April 2024)
• From Dark Matter to Center Stage: The Impact of circRNAs and lncRNAs on Neuronal Health and Disease (Deadline: 30 April 2024)
• New Targeted Therapies in Cancer-2024 (Deadline: 30 April 2024)
• Molecular Mechanisms, Pathogenesis, and Novel Therapeutic Strategies in Cardiovascular Disease (Deadline: 30 April 2024)
• Cellular and Molecular Research of Kidney Diseases 2.0 (Deadline: 30 April 2024)
• Insights into Mechanisms Underlying Cardiovascular Disease (Deadline: 30 April 2024)
• Coumarins as Effective Therapeutic Agents: Mechanism of Action and Diverse Activity (Deadline: 30 April 2024)
• Advanced Molecular Mechanisms and Technologies in Cardiac Regeneration (Deadline: 30 April 2024)
• Understanding the Mechanisms of Mitochondrial Stress and Its Association with Human Diseases (Deadline: 30 April 2024)
• Advances in the Prevention and Treatment of Ischemic Diseases (Deadline: 30 April 2024)
• Roles of Extracellular Vesicles in Cerebrovascular Diseases (Deadline: 30 April 2024)
• Rising of New Signatures in Skeletal Muscle Pathologies and Their Possible Role in Disease Pathogenesis (Deadline: 30 April 2024)
• Musculoskeletal Disease: From Molecular Basis to Therapy (Deadline: 30 April 2024)
• Probing the Role of Metabolomics to Unveil the Molecular Landscape of Cardiovascular Diseases (Deadline: 30 April 2024)
• Comprehensive Insights into Molecular Mechanisms and Pathophysiology of Spinal Cord Injury (Deadline: 30 April 2024)
• Amyloid Hetero-Aggregation 2.0 (Deadline: 30 April 2024)
• Diabetes: From Molecular Basis to Therapy (Deadline: 30 April 2024)
• Pathogenesis and Therapy of Muscular Dystrophies (Deadline: 30 April 2024)
• Emerging Technologies for the Assessment and Treatment of Hemostasis (Bleeding and/or Thrombosis) Disorders (Deadline: 30 April 2024)
• Skin Diseases: From Molecular Mechanisms to Pathology (Deadline: 30 April 2024)
• Molecular Insights in Hepatological Complications (Deadline: 30 April 2024)
• Unlocking the Future of Muscle Disease Treatment: Advancements in Gene Therapy, Antisense Therapeutics and Cutting-Edge Pharmacological Strategies (Deadline: 30 April 2024)
• Functional Defects of Keratinocytes in Inflammatory Skin Diseases 2.0 (Deadline: 30 April 2024)
• Advancements in Molecular Research on Infertility (Deadline: 30 April 2024)
• Molecular Advances in Dental Pulp Tissue Engineering 2.0 (Deadline: 30 April 2024)
• Molecular Linkage between Atherosclerosis and Extracellular Vesicles (Deadline: 30 April 2024)
• Skeletal Muscle Function and Metabolism: Molecular Mechanisms and Treatment (Deadline: 30 April 2024)
• Molecular Mechanisms of Tumor-Induced Cardiac Diseases (Deadline: 30 April 2024)
• Molecular Advances in Bone Metabolism and Disorders (Deadline: 30 April 2024)
• Prostate Cancer: Novel Research and Innovative Therapeutic Strategies (Deadline: 30 April 2024)
• A Commemorative Special Issue in Honor of Prof. Dr. Luigi Fabrizio Rodella: The Founder of the Italian Society of Orofacial Pain (Deadline: 30 April 2024)
• Purinergic Signalling in Physiology and Pathophysiology 2.0 (Deadline: 30 April 2024)
• Molecular Research of Gastrointestinal Disease 2.0 (Deadline: 30 April 2024)
• Role of Mesenchymal Stem Cells in Cancer Cell-Based Therapy (Deadline: 30 April 2024)
• Molecular and Cellular Mechanisms Underlying Gastrointestinal Diseases (Deadline: 30 April 2024)
• COVID-19: Advances in Pathophysiology and Therapeutics (Deadline: 30 April 2024)
• Molecular Advances in Osteoporosis Study (Deadline: 30 April 2024)
• Emerging Molecular Research on Skin Cancer and Inflammatory Skin Diseases (Deadline: 30 April 2024)
• Molecular Research in Breast Cancer: Pathophysiology and Treatment (Deadline: 30 April 2024)
• Osteoarthritis and Gender: From Pathogenetic Factors to Therapeutic Intervention (Deadline: 30 April 2024)
• Endometriosis and Endometriosis-Associated Cancer: Molecular Pathologies, Diagnosis and Therapeutic Strategies (Deadline: 30 April 2024)
• Recent Advances and Insights in Treatment of Urinary Tract Diseases (Deadline: 30 April 2024)
• Molecular Mechanisms of Interleukin/Cytokines in Psychiatric Disorders (Deadline: 30 April 2024)
• Mesenchymal Stem Cells Differentiation in Health and Disease (Deadline: 30 April 2024)
• Melanoma: From Molecular Pathology to Therapeutic Approaches (Deadline: 30 April 2024)
• Molecular Researches on Type 1 Diabetes and Its Complications (Deadline: 30 April 2024)
• The Path to Cure in Parkinson’s Disease: Novel Concepts on Mechanisms, Disease Modifying Treatment, and Prevention (Deadline: 30 April 2024)
• Heart Failure: From Molecular Pathology to Novel Therapeutic Approach (Deadline: 30 April 2024)
• From Pathogenesis to Treatment—New Perspectives in Rheumatology 2.0 (Deadline: 30 April 2024)
• Molecular Pathophysiology of Mineralized Tissues (Deadline: 30 April 2024)
• Molecular Insights into Cancer Therapeutics: Advances in Molecular Biology for Targeted Treatment Strategies (Deadline: 30 April 2024)
• Recent Advances in Molecular Mechanisms Underlying Kidney Diseases: Pathophysiology and Therapeutic Targets (Deadline: 30 April 2024)
• Molecular Insights into Atherosclerosis and Vascular Endothelial Cells (Deadline: 30 April 2024)
• Molecular Aspects of Endometriosis (Deadline: 30 April 2024)
• Skin, Autoimmunity and Inflammation 2.0 (Deadline: 30 April 2024)
• Diagnostic and Therapeutic Advances in the Management of Sepsis and Septic Shock—2nd Edition (Deadline: 30 April 2024)
• Molecular Pathogenesis and Diagnostics of Lung Diseases (Deadline: 30 April 2024)
• Oxidative Stress and Mitochondrial Dysfunction (Deadline: 30 April 2024)
• Recent Advances in Molecular Pathophysiology of Cardiovascular Diseases 2.0 (Deadline: 5 May 2024)
• Regeneration for Spinal Diseases 4.0 (Deadline: 10 May 2024)
• Key Advances in Cardiovascular Diseases (Deadline: 10 May 2024)
• Recent Advances in the Molecular Biology of Transplantation (Deadline: 10 May 2024)
• Molecular Mechanisms and Therapeutic Strategies of Inflammatory Pain (Deadline: 10 May 2024)
• Advances in Salivary and Oral Cavity Diagnostics, Molecular Mechanisms, and Treatment (Deadline: 10 May 2024)
• Forward in Vasculitis: Genetics and Beyond (Deadline: 12 May 2024)
• The Zebrafish Model in Animal and Human Health Research (Deadline: 15 May 2024)
• The Role of Specific Alteration in Neurological Disorders: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 15 May 2024)
• Hematological Malignancies: Molecular Mechanisms and Therapy (Deadline: 15 May 2024)
• Pathology of Gliomas (Deadline: 15 May 2024)
• Lipids and Cardiovascular Disease 2.0 (Deadline: 15 May 2024)
• Advances in Molecular Research on Autoimmune Diseases (Deadline: 15 May 2024)
• Molecular Mechanisms and Treatments of Organ Hypoxia or Ischemia (Deadline: 15 May 2024)
• Molecular Mechanisms and Pathophysiology of Myocardial Disease (Deadline: 15 May 2024)
• Sarcomere Function in Health and Disease 2.0: New Insights from Traditional to Advanced Animal-Free Studies (Deadline: 15 May 2024)
• New Advances in Congenital Disorders—From Molecular Basis (Deadline: 15 May 2024)
• Heart-Brain Interaction: Atrial Fibrillation and Stroke (Deadline: 15 May 2024)
• Recent Molecular Research on Preeclampsia (Deadline: 15 May 2024)
• Short and Long-Term Profound Acid Inhibition: Indications and Concerns (Deadline: 15 May 2024)
• Advancements in Osteoarthritis and Cartilage Regeneration: Pathophysiology and Molecular Mechanisms (Deadline: 15 May 2024)
• Molecular Mechanisms of Sjögren's Syndrome 3.0 (Deadline: 15 May 2024)
• Molecular Advances in Orthopedic Trauma and Therapy (Deadline: 15 May 2024)
• Gastrointestinal Diseases: Molecular Mechanism, Diagnostics, and Novel Therapeutic Approaches (Deadline: 15 May 2024)
• Sleep Apnea and Intermittent Hypoxia (Deadline: 15 May 2024)
• Inflammation in Skin and Joints (Deadline: 15 May 2024)
• Molecular Research on Autophagy (Deadline: 15 May 2024)
• Advanced Molecular Research in Lung Diseases (Deadline: 15 May 2024)
• Hepatocellular Carcinoma in 2023: What Is New on Pathogenesis, Diagnosis and Treatment (Deadline: 15 May 2024)
• Advanced Research on Regenerative Medicine (Deadline: 18 May 2024)
• Male Genitourinary Tumors: Molecular and Cellular Mechanism (Deadline: 20 May 2024)
• Cardiovascular Diseases: Molecular Mechanisms and Potential Therapy (Deadline: 20 May 2024)
• Cancer Stem Cells in Solid Tumors (Deadline: 20 May 2024)
• Molecular Advances and Perspectives in Multiple Sclerosis (Deadline: 20 May 2024)
• Pathophysiology and Novel Therapeutic Strategies of Neurological Diseases (Deadline: 20 May 2024)
• Molecular Advances in Ovarian Cancer (Deadline: 20 May 2024)
• Nuclear Receptors in Health and Diseases 2.0 (Deadline: 20 May 2024)
• Sympathetic Nerves and Cardiovascular Diseases 2.0 (Deadline: 20 May 2024)
• Biosensors for the Early Diagnosis of High-Impact Human Diseases (Deadline: 20 May 2024)
• Molecular and Translational Research on Bone Tumors 2.0 (Deadline: 20 May 2024)
• Transcriptional Therapy and Nucleic Acid-Based Therapeutics: From Molecular Targets to Preclinical Studies 2.0 (Deadline: 20 May 2024)
• Novel Molecular Research Targeting the Application of FFPE Tissue: Development and Updates (Deadline: 20 May 2024)
• Mitochondrial Dysfunction: A Metabolic, Cardiovascular, Neurodegenerative and Neuromuscular Issue 2.0 (Deadline: 20 May 2024)
• Recent Advances in Skin Diseases (Deadline: 20 May 2024)
• Recent Advances in Cystic Fibrosis: Pathophysiology, Molecular Mechanisms and Novel Therapies (Deadline: 20 May 2024)
• Epilepsy: Molecular Mechanisms and Therapies (Deadline: 24 May 2024)
• Molecular Studies of Hematological Malignancies: Emphasis on Development of Flow-Cytometry and Cell-Sorting-Based Technics for Improving Diagnosis (Deadline: 24 May 2024)
• Molecular Mechanisms of Pain and Analgesia (Deadline: 25 May 2024)
• Biomarkers in Rare Diseases 3.0 (Deadline: 25 May 2024)
• Molecular Research of Regulation of Red Blood Cells in Health, Hereditary or Acquired Diseases (Deadline: 25 May 2024)
• Physiological and Pathological Unveilings of Ocular Surface Diseases (Deadline: 25 May 2024)
• Non-coding RNAs' Functionality-Diagnosis and Therapy in Cancer and Other Indications (Deadline: 25 May 2024)
• Molecular Mechanisms and Novel Therapies of Liver Diseases (Deadline: 25 May 2024)
• Anemia and Iron Metabolism: Laboratory Diagnosis, Novel Biomarkers and Environmental Influence (Deadline: 27 May 2024)
• Obesity and Malignancies in Women: Searching for New Molecular Links (Deadline: 29 May 2024)
• Fate of Pancreatic Islets in Type 2 Diabetes—2nd Edition (Deadline: 29 May 2024)
• Apoptosis in Cancer Cells and New Targets for Cancer Therapy (Deadline: 29 May 2024)
• Molecular Advances in Melanoma Therapy (Deadline: 29 May 2024)
• Pathogenetic Factors of Ophthalmological Symptoms in Systemic Diseases (Deadline: 30 May 2024)
• Targeting Blood Vessels in Cancer and Fibrosis (Deadline: 30 May 2024)
• Molecular Insight into Dentistry and Craniofacial Surgery: Celebrating the 110th Anniversary of Dentistry in Italy (Deadline: 30 May 2024)
• Brain Metastasis 2024 (Deadline: 30 May 2024)
• Transglutaminase 2 and Cellular Functions (Deadline: 30 May 2024)
• Lung Cancers: An Update on Molecular Diagnostics and Therapy (Deadline: 30 May 2024)
• Molecular Advances in Liver Fibrosis (Deadline: 30 May 2024)
• Molecular Research in Viral Hepatitis and Liver Cancer (Deadline: 30 May 2024)
• Sleep Apnea and Intermittent Hypoxia 4.0 (Deadline: 30 May 2024)
• Cytokine Signaling in Development, Homeostasis and Disease (Deadline: 30 May 2024)
• Advances on Retinal Diseases 2.0 (Deadline: 30 May 2024)
• Human and Animal Monocytes and Macrophages in Homeostasis and Disease 5.0 (Deadline: 30 May 2024)
• Exploring Molecular Mechanisms of Inflammatory Diseases (Deadline: 30 May 2024)
• Sepsis and Septic Shock: From Molecular Mechanisms to Novel Therapies (Deadline: 30 May 2024)
• Technological and Molecular Advances in Systemic Lupus Erythematosus (Deadline: 30 May 2024)
• Molecular Mechanisms of Musculoskeletal Involvement in Rare Diseases (Deadline: 30 May 2024)
• Molecular Research on Amyloidosis in Pathobiology and Therapy (Deadline: 30 May 2024)
• Recent Advances on Multi-Target Directed Ligands (Deadline: 30 May 2024)
• Molecular Research on Prostate Cancer (Deadline: 30 May 2024)
• Recent Research on Vitamin D Metabolism in Disease (Deadline: 30 May 2024)
• Molecular Research on Pharmacogenetics (Deadline: 30 May 2024)
• Molecular Advances in New Combination Therapies for Cancer (Deadline: 30 May 2024)
• Advances in Molecular Research of Diabetic Cardiomyopathy (Deadline: 30 May 2024)
• Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 4.0 (Deadline: 30 May 2024)
• Molecular Advances in Blood–Brain Barrier, Blood–Cerebrospinal Fluid Barrier and Cerebrospinal Fluid–Brain Barriers (Deadline: 30 May 2024)
• Molecular Mechanisms in Dry Eye Disease: Effects on Pathogenesis, Treatment and Ocular Surgery (Deadline: 30 May 2024)
• Sepsis: From Molecular Mechanisms, Pathophysiology to Novel Therapeutic Approaches 4.0 (Deadline: 30 May 2024)
• Essential Metals in Neurological Diseases and Cancer (Deadline: 30 May 2024)
• Osteoarthritis Biomarkers, Diagnosis and Treatments (Deadline: 30 May 2024)
• New Trends in Diabetes, Hypertension and Cardiovascular Diseases 2.0 (Deadline: 30 May 2024)
• Molecular Mechanisms and New Therapies for Breast Cancer (Deadline: 30 May 2024)
• Epigenomics in Cancer Research: A Comprehensive Approach (Deadline: 30 May 2024)
• Retinal Diseases and Macular Degeneration: Cell Biology and Molecular Genetics (Deadline: 30 May 2024)
• Molecular Mechanisms and Therapeutic Advances in Brain Metastasis (Deadline: 30 May 2024)
• Cellular and Molecular Targets of Preeclampsia (Deadline: 31 May 2024)
• Cutaneous Biology, Molecular Dermatology and Dermatopathology (Deadline: 31 May 2024)
• Molecular Advances in Dry Eye Syndrome (Deadline: 31 May 2024)
• Novel Insight into Pulmonary Vascular Disease (Deadline: 31 May 2024)
• Advanced Progress and Application of Photodynamic Therapy (Deadline: 31 May 2024)
• Mechanism Research and Disease Assessment of Drug-Induced Liver Injury (Deadline: 31 May 2024)
• Retinal Diseases: From Molecular Pathology to Therapies (Deadline: 31 May 2024)
• Oral Cancer and Disease in Humans and Animals (Deadline: 31 May 2024)
• Molecular and Translational Research in Cardiovascular Endocrinology, Cardio-Metabolic Diseases and Non-alcoholic Fatty Liver Disease (NAFLD) (Deadline: 31 May 2024)
• Molecular Mechanisms of Acquiring Resistance to Treatments in Prostate Cancer: Perspectives of Old and New Organelles (Deadline: 31 May 2024)
• Advances in Antimicrobial and Antiviral Nanoparticles  (Deadline: 31 May 2024)
• Advances in Breast and Ovarian Cancers: Pathogenetic Mechanisms, DNA Damage and Advanced Therapies (Deadline: 31 May 2024)
• Dermatology: Advances on Pathophysiology and Therapies 2.0 (Deadline: 31 May 2024)
• Genetic, Functional and Therapeutic Aspects of Procoagulant and Anticoagulant Factors 2.0 (Deadline: 31 May 2024)
• The Role of Extracellular Matrix Proteins in Pathogenesis (Deadline: 31 May 2024)
• Progress and Future Directions on Physical Activity and Skeletal Muscle Research in Chronic Kidney Disease (Deadline: 31 May 2024)
• Chronic Hypoxia and Inflammation in Human Pathology (Deadline: 31 May 2024)
• Molecular Diagnostics and Therapeutic Target in Bladder Cancer (Deadline: 31 May 2024)
• Recent Advances in Hypertension and Cardiovascular Disease (Deadline: 31 May 2024)
• Eosinophilic Esophagitis: Molecular Mechanisms, Diagnosis, and Therapeutic Strategies (Deadline: 31 May 2024)
• Molecular and CelluIar Mechanisms of Valvular Heart Disease (Deadline: 31 May 2024)
• From Molecular Mechanism to Therapy in Autism Spectrum Disorder 2.0 (Deadline: 31 May 2024)
• Advances in Molecular Research of Cartilage 2.0 (Deadline: 31 May 2024)
• Updates on Prostate Cancer Research: Molecular Diagnostic Biomarker (Deadline: 31 May 2024)
• Atherosclerosis: From Molecular Basis to Therapy (Deadline: 31 May 2024)
• Recent Molecular Advances in the Pathology and Therapeutics of Musculoskeletal Disease (Deadline: 31 May 2024)
• Autophagy and Kidney Diseases (Deadline: 31 May 2024)
• Molecular Advances in Lung Diseases 2.0 (Deadline: 31 May 2024)
• Role of Epigenetics in Degenerative and Inflammatory Rheumatic Diseases (Deadline: 31 May 2024)
• New Perspective in the Molecular Pathways Involved in Acute and Chronic Lung Injury (Deadline: 31 May 2024)
• Wound Repair and Regeneration 2023 (Deadline: 31 May 2024)
• Aquaporins in Brain Disease 2.0 (Deadline: 31 May 2024)
• Research Advances in Emerging Infectious Diseases (Deadline: 31 May 2024)
• Signalling Pathway and Regulation of Oxidative Stress in Lung Diseases (Deadline: 31 May 2024)
• Biomarkers for Cardiometabolic Risk: Pathophysiology, Impact, Advances and Challenges (Deadline: 31 May 2024)
• Cancer Diagnosis and Treatment: Exploring Molecular Research (Deadline: 31 May 2024)
• New Treatment for Retinal Diseases (Deadline: 31 May 2024)
• The Molecular Basis of Extracellular Vesicles in Health and Diseases (Deadline: 31 May 2024)
• In Honor of Elie Metchnikoff, a Nobel Prize Winner, Who Discovered Macrophages as Phagocyte Cells Involved in the Process of Innate Immunity (Deadline: 31 May 2024)
• Exposome and Mechanisms of Brain Pathology: From Single Cell to Cerebral Networks and Behavior (Deadline: 31 May 2024)
• Recent Research on Cell and Molecular Biology (Deadline: 10 June 2024)
• Molecular Mechanisms of Viral Infection in Pregnancy (Deadline: 10 June 2024)
• Pharmacological Approaches and Models of Physical Activity in the Treatment of Inflammatory Diseases and Cancer (Deadline: 10 June 2024)
• Recent Molecular Biology on Ovarian Cancer and Prostate Cancer (Deadline: 10 June 2024)
• Unveiling the Dynamic World of Adaptive Unfolded Protein Responses in Metabolic Disease: A Scientist’s Perspective (Deadline: 10 June 2024)
• Ischemic Retinal Diseases: Pathophysiology, Retinal Imaging and Therapeutics (Deadline: 10 June 2024)
• Molecular Research on Skeletal Muscle Diseases (Deadline: 15 June 2024)
• Gynecological Cancer: Targeted Therapeutics and Future Perspectives (Deadline: 15 June 2024)
• Molecular Advances in Muscular Dystrophy (Deadline: 15 June 2024)
• Molecular Advances in Gut Microbiota and Intestinal Diseases (Deadline: 15 June 2024)
• Molecular Research of Biomedical X-ray Fluorescence Imaging (XFI) (Deadline: 15 June 2024)
• Molecular Advances and Perspectives of Lung Disease (Deadline: 15 June 2024)
• Insights on the Role of Stem Cells in Tendon Tissue Engineering: From Basic Science to Translational Medicine (Deadline: 15 June 2024)
• Inflammatory Bowel Disease’s Journey: From Metabolism and Immunity to New Therapeutic Horizons (Deadline: 15 June 2024)
• New Molecular Progression of Neuro-Orthopaedics: Musculoskeletal Disorders Caused by Neuromuscular Diseases (Deadline: 15 June 2024)
• Regulation Mechanism of Osteoblast/Osteoclast Differentiation (Deadline: 15 June 2024)
• Molecular and Metabolic Insights into Age-Related Macular Degeneration (Deadline: 15 June 2024)
• The Role of Antithrombin in Blood Disorders (Deadline: 15 June 2024)
• Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment 2.0 (Deadline: 16 June 2024)
• Hydrogen Sulfide and H₂S Donors in Cardiovascular, Metabolic, and Inflammatory Diseases (Deadline: 20 June 2024)
• Polycystic Ovary Syndrome: From Molecular Mechanisms to Therapies 3.0 (Deadline: 20 June 2024)
• Molecular Mechanisms of Retinal Diseases: An Update (Deadline: 20 June 2024)
• Immune Evasion and Pathological Prognostic Biomarkers in Bladder Cancer (Deadline: 20 June 2024)
• Pulmonary Hypertension: Pre-clinical Research on New Molecular Targets and Therapeutic Strategies (Deadline: 20 June 2024)
• Bridging the Gap: Exploring the Link between Metabolic Disorders and Musculoskeletal Diseases (Deadline: 20 June 2024)
• Lipoprotein(a) and Cardiovascular Diseases (Deadline: 20 June 2024)
• Towards an Understanding of Retinal Diseases and Novel Treatment 3.0 (Deadline: 20 June 2024)
• Diabetes and Its Complications: From Molecular Mechanisms to Novel Therapeutic Approaches (Deadline: 20 June 2024)
• Functional Molecules in Tracing and Cancer Therapeutics (Deadline: 20 June 2024)
• Recent Perspectives on Oxidative Stress, Metabolic and Inflammatory Diseases (Deadline: 20 June 2024)
• The Epigenetic Landscape in Cancer (Deadline: 20 June 2024)
• Schizophrenia: From Molecular Mechanism to Therapy (Deadline: 20 June 2024)
• Molecular Pathophysiology of Lung Diseases (Deadline: 20 June 2024)
• The Role of Natural and Synthetic Sulfur Compounds in Human Health and Diseases (Deadline: 20 June 2024)
• Current Molecular Progress on Cell and Gene Therapies (Deadline: 20 June 2024)
• Molecular Mechanisms of Cardiovascular Disease 2024 (Deadline: 20 June 2024)
• Molecular Mechanisms and Targeted Therapies of Breast Cancer (Deadline: 20 June 2024)
• Molecular Diagnosis and Treatment of Inflammatory Bowel Disease (Deadline: 20 June 2024)
• Fractalkine (CX3CL1) and Its Chemoattractant and Adhesion Molecule Properties in Health and Disease (Deadline: 20 June 2024)
• New Molecular Biology and Perspective: Heart Failure (Deadline: 20 June 2024)
• 10th Anniversary of the Institute of Fundamental Medicine and Biology, Kazan Federal University (Deadline: 20 June 2024)
• Acute Radiation Syndrome and Therapies after Combined Radiation Injury (Deadline: 20 June 2024)
• Recent Progress in Regenerative Therapy Using Blood-Derived Biomaterials (Deadline: 20 June 2024)
• Highlights in Pathophysiology of the Musculoskeletal System 2.0 (Deadline: 20 June 2024)
• New Insights into Oxidative Stress and Inflammation in Chronic Diseases (Deadline: 20 June 2024)
• Epigenetic Mediators Inducing Pathophysiological Changes in Cardiac Diseases (Deadline: 20 June 2024)
• Molecular Pathogenesis of Intervertebral Disc Disease (Deadline: 25 June 2024)
• Molecular Insights into Metabolic Pathways and Age-Related Pathologies (Deadline: 25 June 2024)
• Molecular Insights into Muscular Dystrophy (Deadline: 25 June 2024)
• Liver Diseases: From Molecular Basis to Potential Therapy (Deadline: 25 June 2024)
• New Challenges of Parkinson’s Disease (Deadline: 25 June 2024)
• Molecular Mechanisms and Therapeutic Targets in Skin Diseases (Deadline: 28 June 2024)
• Molecular Research of Hepatocellular Carcinoma (Deadline: 28 June 2024)
• Type 1 Diabetes: Cellular and Molecular Pathophysiology (Deadline: 28 June 2024)
• Advances in Molecular and Translational Medicine 2.0 (Deadline: 28 June 2024)
• Molecular Mechanism in Multiple Sclerosis and Related Disorders 2.0 (Deadline: 28 June 2024)
• Vitamins: Molecular Mechanisms and Biological Function (Deadline: 28 June 2024)
• Cytokines: From Cancer to Autoimmunity 2.0 (Deadline: 28 June 2024)
• Mucopolysaccharidoses: Diagnosis, Treatment and Management 4.0 (Deadline: 28 June 2024)
• Zebrafish as a Model in Human Disease 3.0 (Deadline: 28 June 2024)
• The Endothelial Glycocalyx: Physiological, Pathological and Therapeutic “Holy Grail” (Deadline: 29 June 2024)
• Advances in Understanding Molecular Mechanisms Involved in Chronic Kidney Injury and Repair (Deadline: 29 June 2024)
• Coronavirus Disease (COVID-19): Pathophysiology 5.0 (Deadline: 29 June 2024)
• Looking into the Skin in Health and Disease: From Microscopy Imaging Techniques to Molecular Analysis 2.0 (Deadline: 29 June 2024)
• Virus and Cancers: Association with the Disease and Therapies (Deadline: 30 June 2024)
• Insights into Oral Squamous Cell Carcinoma (Deadline: 30 June 2024)
• New Technologies and Applications in Proteomics Research (Deadline: 30 June 2024)
• Research Progress on the Mechanism and Treatment of Cardiomyopathy (Deadline: 30 June 2024)
• Exosomes in Health and Diseases (Deadline: 30 June 2024)
• Molecular Advances in Pediatric Diseases (Deadline: 30 June 2024)
• New Advances in Proteomics in Disease (Deadline: 30 June 2024)
• Age-Related Vascular Physiology (Deadline: 30 June 2024)
• Molecular Insights into Kidney Injury and Repair (Deadline: 30 June 2024)
• Innovations in Molecular Treatment of Hematological Malignancies (Deadline: 30 June 2024)
• Molecular Biology of Liver Diseases: Pathogenesis, Diagnostics and Treatment (Deadline: 30 June 2024)
• Molecular Advances in Heart Disease: Genomics, Proteomics, and Bioinformatics of Heart Research (Deadline: 30 June 2024)
• Molecular Mechanisms Related to Burns, Burn Wound Healing and Scarring 3.0 (Deadline: 30 June 2024)
• Cellular and Molecular Mechanisms of Pathogenesis and Drug Effects in Tuberculosis (Deadline: 30 June 2024)
• New Advances in Inflammasomes (Deadline: 30 June 2024)
• Inflammatory Diseases: From a Molecular Perspective (Deadline: 30 June 2024)
• Autoimmune and Autoinflammatory Disorders: Current Issue and Future Perspectives (Deadline: 30 June 2024)
• Paroxysmal Nocturnal Hemoglobinuria: Pathophysiology and Novel Therapeutic Approaches (Deadline: 30 June 2024)
• Advances in and Insights into the Treatment of Glaucoma (Deadline: 30 June 2024)
• New Insights into Periodontitis: From Biology to Treatment (Deadline: 30 June 2024)
• The Impact of Sex Hormones on Cardiovascular System: Pathophysiological Perspective (Deadline: 30 June 2024)
• Molecular Pathology, Diagnostics and Therapeutics of Nephropathy 3.0 (Deadline: 30 June 2024)
• Advances in Rare Diseases Biomarkers (Deadline: 30 June 2024)
• Molecular Biology in Forensic Science: Past, Present and Future 2.0 (Deadline: 30 June 2024)
• Molecular and Cellular Research on the Glioma and Tumor Microenvironment (Deadline: 30 June 2024)
• Cardiovascular Disease: Molecular Basis, Potential Therapeutic Targets and Translational Research (Deadline: 30 June 2024)
• Adipose Tissue Dynamics in Laminopathies (Deadline: 30 June 2024)
• Unravelling Interactions between Amyloid Beta (Aβ) and Key Pathological Features of Alzheimer’s Disease (Deadline: 30 June 2024)
• Understanding Sepsis: Pathophysiology, Diagnostics and Early Intervention (Deadline: 30 June 2024)
• Mesenchymal Stem/Stromal Cells and Hematological Diseases (Deadline: 30 June 2024)
• Molecular Insight into Retinal Diseases (Deadline: 30 June 2024)
• Molecular and Cellular Mechanisms and the Pathophysiology of Skeletal Muscle Diseases (Deadline: 30 June 2024)
• Molecular Insights into the Developmental Origins of Health and Disease (Deadline: 30 June 2024)
• Molecular Pathogenesis and Therapies for Retinal and Optic Nerve Diseases (Deadline: 30 June 2024)
• Together and Apart: Acute Kidney Injury and Chronic Kidney Disease (Deadline: 30 June 2024)
• Advances in Anti-aging Treatment Development 2.0 (Deadline: 30 June 2024)
• Novel Insights into the Molecular Bases of Congenital Eye Abnormalities (Deadline: 30 June 2024)
• Epigenetic Biomarkers—Technologies and Applications in Complex Disease Diagnostics and Beyond (Deadline: 30 June 2024)
• Regulatory Mechanisms of Ion Channels and Their Potential as Therapeutic Targets 2.0 (Deadline: 30 June 2024)
• Molecular Insights into the Impact of Toxic Metal Accumulation on Human Diseases (Deadline: 30 June 2024)
• Osteoporosis: From Molecular Mechanisms to Therapies 4.0 (Deadline: 30 June 2024)
• Molecular Insights into Lipodystrophy (Deadline: 30 June 2024)
• Role of Drosophila in Human Disease Research 4.0 (Deadline: 30 June 2024)
• Molecular Pathology and New Potential Targeted Therapies in Gastrointestinal Cancers (Deadline: 30 June 2024)
• New Molecular Therapeutic Approaches for Cystic Fibrosis (Deadline: 30 June 2024)
• Molecular Mechanisms of Atherosclerosis (Deadline: 30 June 2024)
• Leukemia: Present and Future (Deadline: 30 June 2024)
• Therapeutic Potential of Antioxidants in the Prevention of Human Diseases (Deadline: 30 June 2024)
• Advances in Lung Inflammation, Injury, and Repair (Deadline: 30 June 2024)
• Molecular Mechanisms of the Pathogenesis of Antiphospholipid Syndrome (APS) (Deadline: 30 June 2024)
• Pulmonary Arterial Hypertension: From Molecular Mechanisms to Novel Therapeutic Approaches (Deadline: 30 June 2024)
• Recent Advances in Photobiomodulation Therapy (PBMT) (Deadline: 30 June 2024)
• Multifaceted World of Chemically Modified Oligonucleotides for Nucleic Acid Therapeutics (Deadline: 30 June 2024)
• Immunoregulation within the Tumor Microenvironment: Special Emphasis on Macrophages and NK Cells (Deadline: 30 June 2024)
• Molecular Insights into Dental Materials and Oral Disease (Deadline: 30 June 2024)
• Retinal Degenerative Diseases 2.0 (Deadline: 30 June 2024)
• Molecular Advances and Therapeutic Strategies in Renal Failure (Deadline: 30 June 2024)
• Molecular Advance on the Pathogenesis and Treatment of Asthma (Deadline: 30 June 2024)
• Anticancer Medicine and Cancer Immunotherapy (Deadline: 30 June 2024)
• Advances in Lung Injury, Regeneration, and Fibrosis 2.0 (Deadline: 30 June 2024)
• Molecular Genetics of Human Leucocyte Antigen in Diseases (Deadline: 30 June 2024)
• Heartfulness: Contributors of Healthy and Unhealthy Cardiac Aging (Deadline: 30 June 2024)
• Interrelation between Heart Failure and Chronic Kidney Disease: A Focus on Molecule Mechanisms (Deadline: 30 June 2024)
• Molecular Mechanisms of Human Liver Diseases 2.0 (Deadline: 30 June 2024)
• Identification of New Molecular Subgroups in Breast Cancer (Deadline: 30 June 2024)
• Cellular and Molecular Mechanisms in Oxidative Stress-Related Diseases 3.0 (Deadline: 30 June 2024)
• Metabolic Mechanisms of Cardiac Injury (Deadline: 30 June 2024)
• Bioactive Lipids and Their Derivatives in Biomedical Applications (Deadline: 30 June 2024)
• Novel Insight into Microcirculation and Microvascular Diseases (Deadline: 30 June 2024)
• Pregnancy Complicated by Hypertension—New Horizons in the Pathomechanism, Diagnosis, and Treatment (Deadline: 30 June 2024)
• Pathogenesis and Novel Therapeutic Approaches for Sarcomas (Deadline: 30 June 2024)
• Molecular Mechanisms of Retinal Degeneration and How to Avoid It 2.0 (Deadline: 30 June 2024)
• Novel Insights into Retinal Disease Pathophysiology and Therapies 3.0 (Deadline: 30 June 2024)
• Personalized Cancer Treatment: Harnessing the Power of Molecular Research (Deadline: 30 June 2024)
• Molecular Research on Thyroid and Thyroid Nodules (Deadline: 4 July 2024)
• Molecular and Cellular Biology of Breast Cancer (Deadline: 10 July 2024)
• Molecular Advances in Liver Inflammation and Fibrosis (Deadline: 10 July 2024)
• Genetic Bases of Neurodegenerative Disease (Deadline: 10 July 2024)
• Molecular Research on Embryo Developmental Potential (Deadline: 10 July 2024)
• Recent Advancements in Organ Transplantation: From Organ Protection to Molecular Therapy (Deadline: 10 July 2024)
• Cellular and Molecular Biology of Cardiac Hypertrophy and Heart Failure: Pathogenesis, Diagnostics and Treatment (Deadline: 15 July 2024)
• Molecular Insights into Pathogenesis and Therapy of Muscular Dystrophies (Deadline: 15 July 2024)
• Athlete's Heart: From Cellular–Molecular Mechanism to Structural Anomalies (Deadline: 15 July 2024)
• The Role of Lysosomal Proteases in Cancer and Infectious Diseases (Deadline: 15 July 2024)
• Targeting Collagen-Related Therapy (Deadline: 15 July 2024)
• Heart Disease and Its Complications: From Molecular Mechanisms to Therapy (Deadline: 15 July 2024)
• Advances in Molecular Research on Neuroprotective Approaches to Stroke (Deadline: 15 July 2024)
• Latest Advances in Skin Disease: Pathophysiological Mechanisms and Treatment Strategies (Deadline: 20 July 2024)
• Advances in Prostate Cancer Diagnostics and Therapy (Deadline: 20 July 2024)
• Environmental Pollutants and Lung Diseases: Cellular and Molecular Mechanisms (Deadline: 20 July 2024)
• A Commemorative Issue Honoring Biomolecular Scientists in the Post-COVID-19 Pandemic Era (Deadline: 20 July 2024)
• Chronic Obstructive Pulmonary Disease (COPD): Molecular Mechanisms and Treatment (Deadline: 20 July 2024)
• New Molecular Insights into Scar and Wounds (Deadline: 20 July 2024)
• Aging in Cardiovascular Diseases (Deadline: 20 July 2024)
• Male Genitourinary Tumors: Molecular Mechanisms and Potential Therapeutic Targets (Deadline: 25 July 2024)
• Advanced Research of Skin Inflammation and Related Diseases (Deadline: 25 July 2024)
• Latest Updates about Interstitial Lung Disease (Deadline: 25 July 2024)
• Recent Advances in the Diagnosis and Treatment of Chronic Liver Diseases 2023 (Deadline: 25 July 2024)
• C. elegans as a Disease Model: Molecular Perspectives (Deadline: 25 July 2024)
• Endothelial Dysfunction and Cardiovascular Diseases (Deadline: 25 July 2024)
• Molecular Physiological and Pathological Progression of Neurological Diseases (Deadline: 25 July 2024)
• Lung Transplantation and Lung Diseases: Molecular Pathogenesis and Advanced Therapies (Deadline: 25 July 2024)
• Advances in Neurodegenerative Diseases and Inflammation: Pathogenesis, Biomarkers and Treatments (Deadline: 26 July 2024)
• Advances in Skin Cancer Pathology: From Pathogenesis to Precision Therapies (Deadline: 26 July 2024)
• Molecular Research in Pregnancy, Childbirth, and Related Complications (Deadline: 26 July 2024)
• Acute Respiratory Distress Syndrome (ARDS): New Insights into the Mechanisms and Emerging Therapies (Deadline: 28 July 2024)
• The Role of Red Blood Cell Hemodynamic Functionality in Health and Disease (Deadline: 28 July 2024)
• Molecular Diagnostics and Therapeutics of Epileptic Neurodevelopment (Deadline: 28 July 2024)
• New Insights into Liver Biology and Disease Pathogenesis: Shedding Light on Novel Diagnostic and Therapeutic Approaches (Deadline: 29 July 2024)
• Molecular and Cellular Research in Pregnancy-Related Complications 2.0 (Deadline: 30 July 2024)
• Cutting-Edge Insights into Oral Health and Disease (Deadline: 30 July 2024)
• Molecular Pathophysiology of Myositis (Deadline: 30 July 2024)
• Reproductive-Related Disorders: Molecular Pathogenesis, Diagnosis and Treatment (Deadline: 30 July 2024)
• Biomolecules in the Treatment of Biofilm-Related Diseases (Deadline: 30 July 2024)
• Molecular Pathology Research on Blood Tumors (Deadline: 30 July 2024)
• Molecular Insights in Dental Pulp Treatment (Deadline: 30 July 2024)
• New Breakthroughs in Molecular Diagnostic Tools for Human Diseases (Deadline: 30 July 2024)
• Advances in Therapeutics against Eukaryotic Pathogens (Deadline: 30 July 2024)
• Zebrafish in the Investigation of Organelle Diseases (Deadline: 30 July 2024)
• Molecular Advances in Retinal Diseases (Deadline: 30 July 2024)
• Molecular Diagnosis and Treatments of Diabetes Mellitus (Deadline: 30 July 2024)
• Lipid Metabolism in Heart (Deadline: 30 July 2024)
• Lymphatic System in Vascular Disease (Deadline: 30 July 2024)
• Recent Advances of Biochemistry and Molecular Biology of Infectious Diseases, 2nd Edition (Deadline: 30 July 2024)
• Molecular Insights into Skin Health and Pathology (Deadline: 30 July 2024)
• Molecular Basis and Treatment of Skin Diseases and Their Associated Complications (Deadline: 30 July 2024)
• Cardioprotection in Drug-Induced Cardiotoxicity (Deadline: 30 July 2024)
• Atherosclerosis 2.0: From Molecular Mechanisms, Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 July 2024)
• Physiology and Pathophysiology of Placenta 2.0 (Deadline: 30 July 2024)
• Advances of Molecular Research in Reproductive Endocrinology (Deadline: 30 July 2024)
• Advanced Therapies for Inherited Diseases and Cancer: Recent Progress (Deadline: 30 July 2024)
• The Role of Protease and Protease Inhibitors in Human Diseases (Deadline: 30 July 2024)
• Molecular Basis and Therapy of Optic Neuropathies (Deadline: 31 July 2024)
• Cardiomyopathy: From Pathologies to Therapy (Deadline: 31 July 2024)
• Autoimmunity Disease and Viral Infections (Deadline: 31 July 2024)
• Ischemia Reperfusion Injury: A Cell Signaling Crossroads and Therapeutics 2.0 (Deadline: 31 July 2024)
• How Melanin Affects the Therapy Response of Cutaneous Melanoma? (Deadline: 31 July 2024)
• Pathophysiological and Molecular Insights into Heart Failure: From Diagnosis to Therapy (Deadline: 31 July 2024)
• Molecular Mechanisms and Cell Biology of Pancreatic Diseases (Deadline: 31 July 2024)
• Molecular Landscape of Cutaneous Wound Healing in Health and Disease (Deadline: 31 July 2024)
• Extracellular Vesicles in Microbes, Pathogens and Infectious Diseases 2.0 (Deadline: 31 July 2024)
• New Perspectives in Hematopoietic Stem Cell and Leukemia (Deadline: 31 July 2024)
• The Role of Astrocytes in Human Diseases (Deadline: 31 July 2024)
• Role of Mitochondria in Diseases (Deadline: 31 July 2024)
• Molecular Insights into Colitis (Deadline: 31 July 2024)
• Pulmonary Fibrosis: Molecular Pathology, Diagnosis, and Therapeutic Strategies (Deadline: 31 July 2024)
• Cystic Fibrosis: Molecular Pathogenesis, Diagnosis, and Treatment (Deadline: 31 July 2024)
• Molecular Mediators of Exercise: Cross-Organ Communication Promoting Health and Combating Disease (Deadline: 31 July 2024)
• Omics Sciences for Salivary Diagnostics 2.0 (Deadline: 31 July 2024)
• Advances and Challenges of Molecular Research on Disease in Animal Models in Biomedicine (Deadline: 31 July 2024)
• Molecular Insight into Zoonotic Infections (Deadline: 31 July 2024)
• Molecular Insights to Improve Outcomes of Pregnancy Complications (Deadline: 31 July 2024)
• Genetic Research in Cardiac Diseases (Deadline: 31 July 2024)
• Molecular Pathogenesis and Therapeutics in Viral Hepatitis (Deadline: 31 July 2024)
• Chronic Pain: Diagnosis, Pathophysiological Mechanisms and Treatment (Deadline: 31 July 2024)
• Molecular Advances in Periodontitis Diagnosis and Treatment (Deadline: 31 July 2024)
• Vitamin D Signaling in Human Health and Diseases (Deadline: 31 July 2024)
• Growth Hormone Deficiency: Molecular Pathologies and Therapeutic Strategies (Deadline: 31 July 2024)
• Recent Advances in Gluten-Related Disorders (Deadline: 31 July 2024)
• Molecular Insights into Hair Regeneration (Deadline: 31 July 2024)
• Molecular Research in Three-Dimensional Model Systems for Pharmacological Approaches (Deadline: 31 July 2024)
• Pathogenesis and Novel Therapeutics in Breast Cancer (Deadline: 31 July 2024)
• Advanced Research on Wound Healing 2.0 (Deadline: 31 July 2024)
• Dry Eye and Ocular Surface Disorders 5.0 (Deadline: 31 July 2024)
• Immunotherapy-Based Combinations in Thoracic Malignancies (Deadline: 31 July 2024)
• Advances in the Pathophysiology and Treatment of Diabetic Retinopathy (Deadline: 31 July 2024)
• Molecular and Genetic Studies on Tourette Syndrome and Comorbid Disorders (Deadline: 31 July 2024)
• New Insights into the Use of Mouse Models for the Study of Musculoskeletal Diseases (Deadline: 31 July 2024)
• Cutting-Edge Research and Applications of Extracellular Microvesicles in Disease Management (Deadline: 31 July 2024)
• Molecular Mechanisms Underlying the Progression of Prostate Cancer (Deadline: 31 July 2024)
• Multidrug Resistance in Cancer: Molecular Mechanisms and Therapeutic Implications (Deadline: 31 July 2024)
• Exploring the Therapeutic Potential of Modulators of Regulated Cell Death for Retinal Atrophy (Deadline: 31 July 2024)
• The bHLH Transcription Factors Intrinsic Disorder and Disease (Deadline: 31 July 2024)
• The Role of microRNA in Human Diseases 3.0 (Deadline: 31 July 2024)
• New Therapies for Acute Myeloid Leukemia (Deadline: 31 July 2024)
• Molecular Pathways in Myocardial Dysfunction and Cardioprotection (Deadline: 31 July 2024)
• Recent Developments and Updates in Acute Lymphoblastic Leukemia (Deadline: 31 July 2024)
• Molecular Pathogenesis and Therapeutics in Retinopathy (Deadline: 31 July 2024)
• Diabetes-Related Cognitive Impairment Diseases (Deadline: 10 August 2024)
• Molecular Advances in Glomerular Diseases (Deadline: 15 August 2024)
• Molecular Research of Osteosarcoma Pathology and the Latest Therapies (Deadline: 15 August 2024)
• Photodynamic Therapy and Photodetection, 2nd Edition (Deadline: 15 August 2024)
• Molecular Advances in Myocardial Fibrosis (Deadline: 20 August 2024)
• Breast Cancer: Molecular Pathology, Diagnosis, and Therapeutic Strategies (Deadline: 20 August 2024)
• Systemic Sclerosis: Molecular Research and Novel Therapy (Deadline: 20 August 2024)
• Molecular Mechanisms and Therapy of Cardiomyopathy (Deadline: 20 August 2024)
• Molecular Insights in Hepatic Disease and Hepatocellular Carcinoma (Deadline: 20 August 2024)
• Molecular Research in Chronic Kidney Disease (Deadline: 20 August 2024)
• New Cellular and Molecular Insights into Glaucoma (Deadline: 25 August 2024)
• Molecular Advances in Mental Health and Disorders (Deadline: 25 August 2024)
• The Role of Heat Shock Proteins: From Molecular Mechanisms to Therapeutics 2.0 (Deadline: 25 August 2024)
• Molecular Mechanisms and Therapeutic Targets in Multiple Myeloma (Deadline: 26 August 2024)
• Lipoproteins—Opportunities for the Development of Nanotherapeutics in Chronic Disease (Deadline: 28 August 2024)
• Sustainable Approaches in Skin Conditions 3.0 (Deadline: 28 August 2024)
• Neurodegeneration: From Genetics to Molecules 2.0 (Deadline: 28 August 2024)
• Targeting Breast Cancer: Strategies and Hope 2.0 (Deadline: 28 August 2024)
• Biomaterials for Wound Healing and Tissue Regeneration (Deadline: 29 August 2024)
• Advances in Cardiovascular Remodeling (Deadline: 29 August 2024)
• Pathophysiological Research into and Treatment of Pregnancy Complications (Deadline: 30 August 2024)
• Natural Products in Lifestyle-Related Diseases: Molecular Mechanisms, Prevention and Treatments (Deadline: 30 August 2024)
• Molecular Pathways and Therapeutic Strategies for Fibrotic Conditions (Deadline: 30 August 2024)
• Bone Tissue Engineering: Opportunities and Challenges (Deadline: 30 August 2024)
• The Role of Nuclear Medicine in Cancer Diagnosis and Therapy (Deadline: 30 August 2024)
• Molecular Aspects of Photodynamic Therapy (Deadline: 30 August 2024)
• Advances in Gastrointestinal Disease: Exploring the Interplay between Inflammation, Autoimmunity, and Cancer (Deadline: 30 August 2024)
• Exploring the Molecular, Cellular, and Physiological Basis of Hearing Disorders (Deadline: 30 August 2024)
• Molecular Advances in Skin Diseases 3.0 (Deadline: 30 August 2024)
• Cellular and Molecular Biology in the Compromised Neonate (Deadline: 30 August 2024)
• Challenges and Advances of Therapeutic Approaches in Human Diseases: Focus on Stem Cell Therapies (Deadline: 30 August 2024)
• New Insights into the Use of Mouse Models for the Study of Skin Disorders (Deadline: 30 August 2024)
• Molecular Insights into Liver Diseases (Deadline: 30 August 2024)
• CDKL5 Deficiency Disorders: From Molecular Mechanisms to Therapeutics (Deadline: 30 August 2024)
• Recent Advances in Immunotherapy for Breast Cancer (Deadline: 30 August 2024)
• Photodynamic Therapy for Cancer Treatment (Deadline: 30 August 2024)
• New Applications in the Diagnosis and Therapy of Diseases 2.0 (Deadline: 30 August 2024)
• New Insights into the Pathogenesis of Type 1 Diabetes (Deadline: 30 August 2024)
• Heart Failure: From Molecular Basis to Therapeutic Strategies (Deadline: 30 August 2024)
• Molecular Advances in Neuroprotective Strategies for Ocular Diseases (Deadline: 30 August 2024)
• From Bench to Bedside: Well-Established and Emerging Preclinical Models in Cardiovascular Research (Deadline: 30 August 2024)
• Celiac Disease: Genetics, Pathogenesis and Therapy 2.0 (Deadline: 30 August 2024)
• Molecular Mechanisms and Regulation in Chronic Kidney Diseases (Deadline: 30 August 2024)
• Inflammatory Airway Diseases: Diagnosis, Pathology, Molecular Mechanisms and Treatment Options (Deadline: 30 August 2024)
• Advanced Research in Gut Inflammation and Gut-Mediated Disorders (Deadline: 30 August 2024)
• Alzheimer’s Disease: Molecular Mechanisms and Pharmacological Approaches (Deadline: 30 August 2024)
• Chronic Viral Hepatitis and Infection-Related Cancer (Deadline: 30 August 2024)
• Viral Diseases of the Respiratory System—Molecular Mechanisms and Pathogenesis 2.0 (Deadline: 30 August 2024)
• Molecular Research in Rheumatoid Arthritis (Deadline: 31 August 2024)
• Splice-Switching Antisense Oligonucleotides: 30 Years after Advocating Exon-Skipping Therapy for Duchenne Muscular Dystrophy (Deadline: 31 August 2024)
• Translational Medicine of Vascular and Lymphatic Diseases: From the Molecule to the Clinic (Deadline: 31 August 2024)
• Molecular Research of Microbial Infection and Phage Therapy (Deadline: 31 August 2024)
• Novel Diagnostic and Preventive Options of Pregnancy Complications Originated from Placental Pathologies (Deadline: 31 August 2024)
• Cellular and Molecular Insights into Ocular Changes Associated with Systemic Disorders and Conditions (Deadline: 31 August 2024)
• Cardiovascular and Cerebrovascular Diseases: From Pathology to Therapeutic Perspectives (Deadline: 31 August 2024)
• Advances in Genomics in the Care of Primary and Secondary Liver Malignancies (Deadline: 31 August 2024)
• Therapeutic Uses of Adult Stem Cells (Deadline: 31 August 2024)
• Molecular Advances and Insights into Liver Diseases (Deadline: 31 August 2024)
• Infectious Diseases: Focus on Molecular Mechanisms and Future Therapy (Deadline: 31 August 2024)
• Molecular Mechanisms of Tendinopathy: Unraveling the Pathogenesis of Tendon Diseases (Deadline: 31 August 2024)
• Muscle Atrophy: From Bench to Bedside 2.0 (Deadline: 31 August 2024)
• Advances in Coagulation and Anticoagulation (Deadline: 31 August 2024)
• Molecular Relationships between Brain and Lung Diseases (Deadline: 31 August 2024)
• Psoriasis: Molecular Research and Novel Therapy (Deadline: 31 August 2024)
• Molecular Pharmacology and Interventions in Cardiovascular Disease (Deadline: 31 August 2024)
• Updates & New Concepts in Collagen 2.0 (Deadline: 31 August 2024)
• New Advances in Osteoarthritis: Molecular Perspective (Deadline: 31 August 2024)
• Multiple Sclerosis: The Latest Developments in Immunology and Therapy (Deadline: 31 August 2024)
• Molecular Insights into Pediatric Brain Tumors: Unraveling the Complexity of Pathogenesis and Identifying New Therapeutic Targets (Deadline: 31 August 2024)
• Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies (Deadline: 31 August 2024)
• Innovative In Vitro Model for Medical, Pharmaceutical and Diagnostic Applications (Deadline: 31 August 2024)
• Update on Molecular Biology and Clinic in Huntington's Disease (Deadline: 31 August 2024)
• Novel Therapies for Schizophrenia: Beyond Dopamine (Deadline: 31 August 2024)
• Adipose Tissue Diseases: Physiopathology, Molecular Mechanism, Diagnosis and Treatment (Deadline: 31 August 2024)
• Protein Methyltransferases in Human Health and Diseases (Deadline: 31 August 2024)
• Molecular Biomarkers in Cancer and Chronic Inflammation: New Therapeutic Approaches (Deadline: 31 August 2024)
• Role of Proteomics in Human Diseases and Infections (Deadline: 31 August 2024)
• Emerging Molecular Concepts in Fibroid Pathogenesis (Deadline: 31 August 2024)
• Rare Diseases and Neuroscience (Deadline: 31 August 2024)
• Phenylketonuria (PKU): Molecular Advances in Pathophysiology and Therapies (Deadline: 31 August 2024)
• Multiple Myeloma: Molecular Mechanisms and Targeted Therapy, 2nd Edition (Deadline: 31 August 2024)
• Kidney Diseases: Molecular Pathogenesis and Therapeutic Strategies 2.0 (Deadline: 31 August 2024)
• Molecular Research on Vascular Disease: Current Status and Future Directions (Deadline: 31 August 2024)
• Advances in Osteogenesis (Deadline: 31 August 2024)
• Beyond Silos: A Comprehensive Understanding of HIV Functional Cure and NeuroHIV (Deadline: 31 August 2024)
• Molecular Mechanisms and Therapies in Skeletal Muscle Diseases (Deadline: 31 August 2024)
• Novel Therapeutic Approaches for Migraine Headaches (Deadline: 31 August 2024)
• Exploring the Glioblastoma Complexity: New Perspectives in the Molecular and Imaging Fields (Deadline: 31 August 2024)
• Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis (Deadline: 31 August 2024)
• Molecular Mechanisms and Therapies of Chronic Obstructive Pulmonary Disease (Deadline: 31 August 2024)
• Molecular and Pathophysiological Mechanisms of Peritoneal Fibrosis in Peritoneal Dialysis (Deadline: 31 August 2024)
• Pathogenesis of Pregnancy-Related Complication 2024 (Deadline: 31 August 2024)
• Molecular Pathology, Diagnostics, and Therapeutics of Kidney Disease (Deadline: 31 August 2024)
• Inflammatory Bowel Disease: Molecular Advances in Pathogenesis and Therapies (Deadline: 31 August 2024)
• Molecular Studies of Bone Biology and Bone Tissue (Deadline: 10 September 2024)
• Molecular Basic Research in Cardiology (Deadline: 10 September 2024)
• Molecular Biology of Liquid Biopsy in Cancer (Deadline: 10 September 2024)
• Genetic Advances in Gastrointestinal Diseases (Deadline: 15 September 2024)
• Molecular Mechanisms of Pregnancy Complications (Deadline: 20 September 2024)
• Advances in the Pathogenesis of Diabetic Kidney Disease: Second Edition (Deadline: 20 September 2024)
• Mitochondria-Mediated Oxidative Stress in Diseases: Cell Death and Treatment (Deadline: 20 September 2024)
• Cardiovascular Diseases: Molecular Mechanisms, Biomarkers, and Therapies (Deadline: 20 September 2024)
• Molecular Research and Insights into COVID-19 2.0 (Deadline: 20 September 2024)
• New Molecular Insights into Ischemia/Reperfusion (Deadline: 20 September 2024)
• Molecular Research on Inflammatory Diseases of the Gut in Humans and Animals (Deadline: 20 September 2024)
• Molecular Advances in Oncologic Photodynamic Therapy (Deadline: 20 September 2024)
• Nucleic Acid-Based Diagnostics for Infectious Diseases (Deadline: 20 September 2024)
• The Molecular and Cellular Mechanisms of Neurodegenerative Diseases 2.0 (Deadline: 20 September 2024)
• Molecular Study of Renal Diseases (Deadline: 20 September 2024)
• Immunotherapy in Cancer: Molecular Basis and Novel Therapeutic Approaches (Deadline: 20 September 2024)
• Molecular Research on Platelet Activity in Health and Disease 2023 (Deadline: 20 September 2024)
• Epigenetic Mechanisms and Human Pathology 4.0 (Deadline: 20 September 2024)
• Targeting Corneal Wound Healing: Molecular Access to Diagnosis, Pathophysiology, and Treatment (Deadline: 20 September 2024)
• Gastrointestinal: Inflammation, Immunity and Cancer Pathways (Deadline: 20 September 2024)
• Molecular Research on Skin Disease: From Pathology to Therapy (Deadline: 20 September 2024)
• Molecular Insights into Thrombosis (Deadline: 20 September 2024)
• Focus on Cartilage Biology (Deadline: 20 September 2024)
• Recent Progress with Duchenne Disease: From Molecular Pathology to Therapies (Deadline: 20 September 2024)
• Evidence-Based Principles of Diagnosis and Management of Hypertension in Modern Era (Deadline: 20 September 2024)
• Molecular Research in Triple-Negative Breast Cancer (Deadline: 20 September 2024)
• New Insights into Kidney Diseases (Deadline: 20 September 2024)
• New Challenges and Perspectives in Polycystic Ovary Syndrome (Deadline: 20 September 2024)
• Molecular Research of Endocytic and Autophagic Pathways in Diseases (Deadline: 20 September 2024)
• Molecular Insights in Heart Failure (Deadline: 20 September 2024)
• Molecular Research on Viral Infection and Host Immunity (Deadline: 20 September 2024)
• Inflammatory Bowel Disease: Molecular Insights (Deadline: 20 September 2024)
• The Relevance of Lipid Metabolism in Viral Hepatitis and Hepatocellular Carcinoma (Deadline: 21 September 2024)
• Molecular Advances in Gestational Diabetes Mellitus (Deadline: 25 September 2024)
• Molecular Pathogenesis and Treatment of Pregnancy Complications (Deadline: 25 September 2024)
• Endothelial Dysfunction and Its Related Cardiometabolic Disorders: From Mechanisms to Targeted Therapies (Deadline: 25 September 2024)
• Cellular and Molecular Progression of Cardiovascular Diseases (Deadline: 25 September 2024)
• Molecular Mechanisms and Treatment of Migraine (Deadline: 27 September 2024)
• Molecular Insight into Oral Diseases (Deadline: 27 September 2024)
• Molecular Insights into Neurodegeneration—Pathways, Diagnosis and Treatment Strategies (Deadline: 28 September 2024)
• Targeting Tumor Angiogenesis: Challenges and Opportunities (Deadline: 28 September 2024)
• Molecular Aspects of Healthy Aging (Deadline: 28 September 2024)
• Bone Marrow Concentrate: New Molecular Research (Deadline: 28 September 2024)
• Current Research for Heart Disease Biology and Therapeutics 2.0 (Deadline: 29 September 2024)
• Apoptosis and Autophagy as Strategies in Cancer Treatment (Deadline: 29 September 2024)
• Lymphatic Disorders: From Molecular Mechanisms to Therapies (Deadline: 29 September 2024)
• Uterine Fibroids: Molecular Pathogenesis and Therapeutic Strategies (Deadline: 29 September 2024)
• Protein–RNA Interactions: Function, Mechanism, and Identification (Deadline: 30 September 2024)
• Pathophysiology and Treatment of Alzheimer's Disease (Deadline: 30 September 2024)
• Periodontitis: Advances in Mechanisms, Treatment and Prevention (Deadline: 30 September 2024)
• 55th Anniversary of IgE Discovery: Pros and Cons of Anti-IgE Treatment (Deadline: 30 September 2024)
• MicroRNA Regulation in Human Health and Diseases (Deadline: 30 September 2024)
• The Roles of Mesenchymal Stem/Stromal Cells in Tumor Therapies (Deadline: 30 September 2024)
• Molecular Research of Ocular Pathologies, 2nd Edition (Deadline: 30 September 2024)
• Ocular Ischemic Diseases: From Molecular Mechanisms to Therapeutics (Deadline: 30 September 2024)
• Oral Cancer: Update on Molecular Pathology, Mechanisms and Treatments (Deadline: 30 September 2024)
• Diabetic Retinopathy—Innovation in Diagnosis and Treatment (Deadline: 30 September 2024)
• Roles and Function of Extracellular Vesicles in Diseases 3.0 (Deadline: 30 September 2024)
• Novel Insights into Monoclonal Antibodies in Disease (Deadline: 30 September 2024)
• Molecular Imaging Study of Atherosclerosis (Deadline: 30 September 2024)
• Sodium Channel in Cardiovascular Diseases and Health (Deadline: 30 September 2024)
• Advancing Redox Biomarkers in Pathological Conditions (Deadline: 30 September 2024)
• Exploring the Complex Interplay between Metabolic Diseases, MASLD, and Liver Cancer (Deadline: 30 September 2024)
• Drug Development in the Prevention and Treatment of COVID-19 (Deadline: 30 September 2024)
• Astrocyte-Endothelial Interactions at the Blood-Brain Barrier 2.0 (Deadline: 30 September 2024)
• A Commemorative Special Issue in Honor of Prof. Giovanni De Toni: A Pediatrician and Innovator at the Gaslini Children’s Hospital, Genoa, Italy (Deadline: 30 September 2024)
• Molecular Pathology and Molecular Pharmacology of Chronic Pain (Deadline: 30 September 2024)
• Molecular Research Progress of Skin and Skin Diseases (Deadline: 30 September 2024)
• Rheumatoid Arthritis: Molecular Mechanisms and Immunotherapy (Deadline: 30 September 2024)
• Resistance Pathways and Innovative Therapies in Glioblastoma (Deadline: 30 September 2024)
• Immunity, Inflammation, and Injury in the Pathogenesis and Progression of Kidney Diseases—from Bench to Bedside (Deadline: 30 September 2024)
• Molecular Mechanisms of Oxidative Stress in Kidney Disease (Deadline: 30 September 2024)
• Cellular Senescence and the Senescence-Associated Secretory Phenotype (SASP) in Age-Related Diseases (Deadline: 30 September 2024)
• Recent Advances in Pathophysiology and Immunology Related to SARS-CoV-2 Infection (Deadline: 30 September 2024)
• Genetic and Metabolic Molecular Research of Lysosomal Storage Disease 4.0 (Deadline: 30 September 2024)
• The Role of Extracellular Vesicles in Inflammatory Diseases (Deadline: 30 September 2024)
• Rheumatoid Arthritis: Pathogenesis and Treatments (Deadline: 30 September 2024)
• Molecular Advances in the Diagnosis and Drug Therapies of Atherosclerotic Cardiovascular Diseases (ASCVD) (Deadline: 30 September 2024)
• Molecular and Cellular Perspectives on Wound Healing (Deadline: 30 September 2024)
• Molecular Biology of Stem Cells (Deadline: 30 September 2024)
• Biomarkers in Cardiovascular Diseases: Diagnosis, Pathology and Treatment (Deadline: 30 September 2024)
• Exploring the Molecular Mechanisms of Chronic Kidney Disease (Deadline: 30 September 2024)
• Utilizing Induced Pluripotent Stem Cells and Cardiomyocytes: From Basic Research to Disease Modeling (Deadline: 30 September 2024)
• Advanced Research Progress of Blood-Brain Barrier (Deadline: 30 September 2024)
• Molecular Insights into Age-Associated Diseases (Deadline: 30 September 2024)
• Thyroid Disorders and Cancers: Molecular Mechanisms and Advanced Therapies (Deadline: 30 September 2024)
• Cellular and Molecular Mechanisms on Wound Healing (Deadline: 30 September 2024)
• Molecular Advances in Artificial Reproduction and Female Health: From Molecular Diagnosis to the Treatment of Gynecological Diseases (Deadline: 30 September 2024)
• Intestinal 3D Culture, Organoids and Gut-on-Chip in Intestinal Disorders (Deadline: 10 October 2024)
• Arteriogenesis, Angiogenesis and Vascular Remodeling 2.0 (Deadline: 20 October 2024)
• Biomarkers for the Diagnosis and Prognosis of Cardiovascular Disease (Deadline: 20 October 2024)
• Emerging Roles of Inflammation in Retinal and Optic Nerve Pathologies (Deadline: 20 October 2024)
• New Insights into the Molecular Mechanisms of Chronic Pain (Deadline: 20 October 2024)
• Molecular Mechanisms and Therapy in Sarcomas (Deadline: 25 October 2024)
• Skin Diseases: From Molecular Pathology to Novel Therapeutic Approaches (Deadline: 25 October 2024)
• Recent Molecular Trends and Prospects in Kidney Diseases (Deadline: 25 October 2024)
• Dental Health and Disease: From the Molecular and Pathological Perspectives (Deadline: 25 October 2024)
• Molecular Insights into the Obstetrics and Gynecology (Deadline: 30 October 2024)
• Molecular Interactions in Inflammatory Skin Diseases (ISDs): The Role of Exosomes and Other Molecular Mediators in Pathogenesis and Therapeutic Strategies (Deadline: 30 October 2024)
• Rare Genetic Diseases: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 31 October 2024)
• Heart Failure Mechanisms and Treatment Advances (Deadline: 31 October 2024)
• Molecular Insights into Reproductive Biology and Related Diseases (Deadline: 31 October 2024)
• Lung Diseases Molecular Pathogenesis and Drug Therapy (Deadline: 31 October 2024)
• Molecular Advances and Insights on Diagnosis, Prevention and Therapeutics of Cardiovascular Diseases (Deadline: 31 October 2024)
• Molecular Research in Gynecological Diseases-2nd Edition (Deadline: 31 October 2024)
• Medical Imaging Technology in Molecular Pathological Mechanisms and Disease Therapies (Deadline: 31 October 2024)
• Beyond Transgenics: Leveraging Humanized Mice for Disease Modeling and Therapeutics (Deadline: 31 October 2024)
• Genetic Basis and Molecular Mechanisms of Heart Failure (Deadline: 31 October 2024)
• Research on Mitochondria and Cell Death in Disease Diagnosis and Treatment (Deadline: 20 November 2024)
• Primary and Secondary Bladder Disorders in Neurourology and Inflammatory Diseases (Deadline: 30 November 2024)
• The Endocannabinoid System: New Insights into Its Role in Health and Disease 2.0 (Deadline: 30 November 2024)
• Myotonic Dystrophies: An Update on Pathology, Molecular Pathogenesis and Therapeutic Approaches (Deadline: 30 December 2024)
• Hepatopancreatic and Intestine Diseases: From Molecular Basis to Therapy (Deadline: 31 December 2024)
• Inflammatory Bowel Disease: Focus on Molecular Research (Deadline: 31 December 2024)
• New Advance on Inflammation and Repair in Respiratory Diseases (Deadline: 31 December 2024)
• Signaling Pathways and Novel Therapies in Heart Disease (Deadline: 31 December 2024)
• Role of Oxidative Stress and Inflammation in Health and Disease (Deadline: 31 January 2025)
• Exosomes and Non-coding RNA Research in Health and Disease (Deadline: 11 June 2025)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Cardiomyopathies: Molecular Insights and Future Perspectives
• Cardiovascular Diseases in Basic Research: New Molecular Insights and Perspectives
• Feature Papers in Molecular Pathology, Diagnostics, and Therapeutics
• Immunopathology and Immunosenescence
• Molecular Understanding of the Exocrine Pancreas and Its Disorders
• Natural Products and Gut Microbiota in Age-Related Diseases
• Programmed Cell Death and Apoptosis
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases in Italy (Closed)
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Head and Neck Diseases in Australia (Closed)
• State-of-the-Art Molecular Mechanisms of Hematopathology in France (Closed)
• State-of-the-Art Molecular Mechanisms of Pulmonary Pathology in USA (Closed)